A health worker shows a box containing a bottle of Ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance (INVIMA) to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Pediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. (Luis Robayo/AFP via Getty Images)
They found «large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.» The authors also said that studies on the prevention of COVID-19 reported significantly reduced risks of the disease with regular use of the drug. Members of the FLCCC Alliance have developed various protocols for the prevention and early treatment of COVID-19, instead of having patients wait until they develop a severe illness to receive treatment at the hospital. These treatment protocols including one for the management of long COVID are being used globally. The current standard protocol for COVID-19 positive patients is to isolate at home, avoid dehydration, rest, and take over-the-counter medications for fever, headache, cough, and body pain.